Human Cardiac Progenitor Cells Enhance Exosome Release and Promote Angiogenesis Under Physoxia

Area of Science:

• Cardiovascular Biology
• Regenerative Medicine
• Exosome Biology

Background:

• Cardiac progenitor cells (CPCs) and their exosomes show limited therapeutic effects for cardiac repair.
• Improving the efficacy of CPC-derived exosomes is crucial for clinical applications.
• Investigating optimal culture conditions for CPCs is needed to enhance exosome therapeutic potential.

Purpose of the Study:

• To evaluate the therapeutic potential of exosomes derived from human CPCs (hCPCs) cultured under varying oxygen levels: normoxia (21%), physoxia (5%), and hypoxia (1%).
• To assess the impact of oxygen conditions on hCPC characteristics and gene expression.
• To determine the effect of physoxia-conditioned hCPC exosomes on angiogenesis.

Main Methods:

• hCPCs were cultured under normoxia, physoxia, and hypoxia.
• Characterization of hCPCs using specific markers (NKX-2.5, GATA-4, c-kit).
• Gene expression analysis using a qPCR array.
• Exosome isolation and quantification via nanoparticle tracking analysis.
• Assessment of exosome-induced angiogenesis using a tube formation assay.

Main Results:

• Physoxia did not alter hCPC proliferation or cell death.
• Physoxia modulated fewer hypoxia-related genes compared to hypoxia.
• Exosome yield was 1.6-fold higher from hCPCs cultured under physoxia.
• Exosomes from physoxia-cultured hCPCs significantly enhanced tube formation for angiogenesis.

Conclusions:

• Physoxia (5% O2) represents a promising condition for culturing hCPCs to maximize exosome production and therapeutic efficacy.
• Physoxia-conditioned hCPC-derived exosomes demonstrate significant potential for promoting angiogenesis and myocardial repair.
• This study highlights the therapeutic potential of optimizing the oxygen microenvironment for CPC exosome-based regenerative therapies.